UV light-blocking contact lenses protect against short-term UVB-induced limbal stem cell niche damage and inflammation
- PMID: 30135547
- PMCID: PMC6105637
- DOI: 10.1038/s41598-018-30021-8
UV light-blocking contact lenses protect against short-term UVB-induced limbal stem cell niche damage and inflammation
Abstract
UVB irradiation has been linked to pathogenesis of pterygium, a conjunctival tumor growing onto transparent cornea, the windscreen of the eye. Due to corneal anatomy, ambient UVB irradiation is amplified at the stem cell-containing nasal limbus. The aim of this study was to analyse the effect of a UV-blocking contact lens (UVBCL, senofilcon A, Class 1 UV blocker) on limbal epithelial cells and fibroblasts under UVB irradiation compared to a non-UVB-blocking contact lens. UVBCL prevented UVB-induced DNA damage (as assessed by cyclobutane pyrimidine dimer immunostaining) as well as a decrease in proliferation and scratch wound closure rate of both limbal epithelial and fibroblast cells. Similarly, UVBCL protected limbal epithelial cells from UVB-induced loss of their phenotype in terms of colony forming efficiency and stem cell marker expression (ABCB5, P63α, integrin β1) compared to controls. Moreover, with UVBCL pro-inflammatory cytokines such as TNFα and MCP1 remained unchanged. These data demonstrate the significance of UV-protection in preserving the limbal niche in response to at least short-term UVB. Our data support the use of UVBCL in protecting limbal niche cells, especially after limbal stem cell transplantation and in patients after pterygium surgery, to help prevent recurrences.
Conflict of interest statement
Maria Notara: Supported by a Johnson and Johnson Vision Investigator-Initiated Study grant to carry out this study. Christoph Ganss: CEO and shareholder of TICEBA GmbH; CEO of RHEACELL GmbH & Co. KG. Andreas Kluth: CSO of TICEBA GmbH; CSO of RHEACELL GmbH & Co. KG. Christoph Maßlo: Project coordinator of RHEACELL GmbH & Co. KG. M.H.F. is inventor or co-inventor of US and international patents assigned to Brigham and Women’s Hospital and/or Boston Children’s Hospital, Boston, MA, and licensed to TICEBA GmbH (Heidelberg, Germany) and RHEACELL GmbH & Co. KG (Heidelberg, Germany). M.H.F. serves as a scientific advisor to TICEBA GmbH and RHEACELL GmbH & Co. KG. and participates in corporate sponsored research collaborations with RHEACELL GmbH & Co. KG.
Figures
References
-
- Bergmanson JP, Pitts DG, Chu LW. Protection from harmful UV radiation by contact lenses. Journal of the American Optometric Association. 1988;59:178–182. - PubMed
-
- Coroneo MT, Muller-Stolzenburg NW, Ho A. Peripheral light focusing by the anterior eye and the ophthalmohelioses. Ophthalmic surgery. 1991;22:705–711. - PubMed
-
- Maloof AJ, Ho A, Coroneo MT. Influence of corneal shape on limbal light focusing. Investigative ophthalmology & visual science. 1994;35:2592–2598. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 667400-2 H2020/EC | Horizon 2020 (European Union Framework Programme for Research and Innovation)/International
- 667400-2 H2020/EC | Horizon 2020 (European Union Framework Programme for Research and Innovation)/International
- 3626 0460 31/Johnson and Johnson (Johnson & Johnson)/International
- BM1302-COST/European Cooperation in Science and Technology (COST)/International
- CU 47/9-1/Deutsche Forschungsgemeinschaft (German Research Foundation)/International
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
